We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+2.77%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$4.19B
AUM Growth
+$135M
Cap. Flow
+$49.5M
Cap. Flow %
1.18%
Top 10 Hldgs %
44.67%
Holding
487
New
37
Increased
209
Reduced
193
Closed
27

Sector Composition

Rank Sector Weight
1 Technology 13.7%
2 Healthcare 5.68%
3 Financials 4.5%
4 Communication Services 3.15%
5 Industrials 2.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTAS icon
376
Cintas
CTAS
$82B
$310K 0.01%
1,648
+18
+1% +$3.39K
IGV icon
377
iShares Expanded Tech-Software Sector ETF
IGV
$13.8B
$309K 0.01%
+2,925
New +$322K
VCSH icon
378
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.6B
$308K 0.01%
3,861
+55
+1% +$4.39K
FDVV icon
379
Fidelity High Dividend ETF
FDVV
$10.2B
$307K 0.01%
5,420
RSPE icon
380
Invesco ESG S&P 500 Equal Weight ETF
RSPE
$68.5M
$305K 0.01%
+10,225
New +$299K
SPGP icon
381
Invesco S&P 500 GARP ETF
SPGP
$2.28B
$301K 0.01%
2,642
-61
-2% -$6.89K
EQX icon
382
Equinox Gold
EQX
$7.13B
$300K 0.01%
21,400
DOCU
383
DocuSign
DOCU
$10.7B
$300K 0.01%
4,388
-3,578
-45% -$247K
CNI icon
384
Canadian National Railway
CNI
$76.2B
$299K 0.01%
3,024
+22
+0.7% +$2.12K
BCRX icon
385
BioCryst Pharmaceuticals
BCRX
$2.23B
$296K 0.01%
37,952
-16,011
-30% -$116K
ARWR icon
386
Arrowhead Research
ARWR
$11.8B
$295K 0.01%
+4,440
New +$218K
VRIG icon
387
Invesco Variable Rate Investment Grade ETF
VRIG
$1.83B
$292K 0.01%
11,622
+139
+1% +$3.49K
VRTX icon
388
Vertex Pharmaceuticals
VRTX
$120B
$288K 0.01%
636
+15
+2% +$6.46K
HDSN
389
Hudson Technologies
HDSN
$262M
$282K 0.01%
41,163
PANW icon
390
Palo Alto Networks
PANW
$279B
$281K 0.01%
1,523
-412
-21% -$83.1K
IWB icon
391
iShares Russell 1000 ETF
IWB
$48.9B
$280K 0.01%
751
-497
-40% -$184K
BDX icon
392
Becton Dickinson
BDX
$46.5B
$277K 0.01%
1,429
-66
-4% -$12.6K
HYD icon
393
VanEck High Yield Muni ETF
HYD
$4.42B
$277K 0.01%
5,424
+263
+5% +$13.4K
BBUS icon
394
JPMorgan BetaBuilders US Equity ETF
BBUS
$9B
$273K 0.01%
2,214
+7
+0.3% +$857
FE icon
395
FirstEnergy
FE
$28B
$272K 0.01%
6,070
-3,008
-33% -$138K
WCC
396
WESCO International
WCC
$17.4B
$268K 0.01%
1,097
-14
-1% -$3.43K
ESE icon
397
ESCO Technologies
ESE
$8.2B
$268K 0.01%
1,371
+212
+18% +$44.7K
AXSM icon
398
Axsome Therapeutics
AXSM
$10.7B
$267K 0.01%
+1,460
New +$204K
CACI icon
399
CACI
CACI
$11.2B
$266K 0.01%
500
RL icon
400
Ralph Lauren
RL
$22.3B
$265K 0.01%
750

Similar funds

Grimes & Company's Q4 2025 Portfolio in Review

As of Q4 2025, Grimes & Company held 487 positions worth $4.19B, up 3.3% from $4.05B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Grimes & Company's Q4 2025 filing shows 37 new, 209 increased, 193 reduced and 27 closed positions. Its largest new stake was iShares 0-3 Month Treasury Bond ETF: 190,372 shares worth $19.1M. The largest sale was State Street Materials Select Sector SPDR ETF, an estimated $20.5M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Financials.

  • Grimes & Company's largest Q4 2025 buy was iShares 0-3 Month Treasury Bond ETF: 190,372 shares worth $19.1M.
  • Grimes & Company added most to State Street Health Care Select Sector SPDR ETF in Q4 2025, an estimated $35.7M increase.
  • Grimes & Company's biggest Q4 2025 reduction was Invesco S&P 500 Equal Weight ETF, cutting an estimated $14.7M.
  • Grimes & Company fully exited State Street Materials Select Sector SPDR ETF in Q4 2025, selling an estimated $20.5M.
  • Grimes & Company's ten largest holdings make up 45% of its $4.19B portfolio in Q4 2025.
  • Grimes & Company opened 37 new positions and closed 27 in Q4 2025.
  • Grimes & Company's portfolio value rose 3.3% quarter-over-quarter to $4.19B.

Based on Grimes & Company's 13F filing for Q4 2025, filed 3 Feb 2026.